Visiting scientist

Research Group Home Page: 

Work address: 
Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE

The Human Lung Cell Atlas: A High-Resolution Reference Map of the Human Lung in Health and Disease.

E-pub date: 01 Jul 2019

A cellular census of human lungs identifies novel cell states in health and in asthma.

E-pub date: 31 May 2019

ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer.

E-pub date: 15 Jan 2018

BaalChIP: Bayesian analysis of allele-specific transcription factor binding in cancer genomes.

E-pub date: 24 Feb 2017

FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness.

E-pub date: 31 Aug 2016

Identification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy.

E-pub date: 31 Aug 2016

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.

E-pub date: 09 Feb 2016

Regulators of genetic risk of breast cancer identified by integrative network analysis.

E-pub date: 31 Jan 2016

Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

E-pub date: 08 Jan 2015

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.

E-pub date: 18 Feb 2014

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.

E-pub date: 05 Dec 2013

Master regulators of FGFR2 signalling and breast cancer risk.

E-pub date: 31 Aug 2013

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.

E-pub date: 04 Apr 2013

FOXA1 and breast cancer risk.

E-pub date: 01 Nov 2012

RedeR: R/Bioconductor package for representing modular structures, nested networks and multiple levels of hierarchical associations.

E-pub date: 24 Apr 2012

A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.

E-pub date: 31 Jul 2011

Fine scale mapping of the breast cancer 16q12 locus.

E-pub date: 15 Jun 2010

FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.

E-pub date: 01 May 2009

Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.

E-pub date: 06 May 2008

Genome-wide association study identifies novel breast cancer susceptibility loci.

E-pub date: 28 Jun 2007

A NF-AT related protein is implicated in the induction of the immunoglobulin kappa 3′-enhancer activity after B cell stimulation.

E-pub date: 01 May 1997

The Ig kappa 3′-enhancer triggers gene expression in early B lymphocytes but its activity is enhanced on B cell activation.

E-pub date: 01 Oct 1996

Regulated activity of the IgH intron enhancer (E mu) in the T lymphocyte lineage.

E-pub date: 01 Jan 1995

Activation of the immunoglobulin kappa 3′ enhancer in pre-B cells correlates with the suppression of a nuclear factor binding to a sequence flanking the active core.

E-pub date: 30 Apr 1994

The importance of the 3′-enhancer region in immunoglobulin kappa gene expression.

E-pub date: 30 Sep 1990

Show all